Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE269265 |
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma [Methylation array]
|
|
12 |
|
Daniel J. Merk | Jun 13, 2024 | ||
GSE269463 |
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
|
|
21 | Daniel J. Merk | Jun 13, 2024 | |||
GSE252459 |
Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.
|
|
|
48 | Jared Andrews | Jun 12, 2024 | ||
GSE224844 |
Trophectoderm biopsies of blastocysts for preimplantation genetic testing following in vitro fertilization and embryo culture increases epigenetic dysregulation in a mouse model [array]
|
|
48 |
|
Eric Alejandro Rhon Calderon | Apr 24, 2024 | ||
GSE225318 |
Trophectoderm biopsies of blastocysts for preimplantation genetic testing following in vitro fertilization and embryo culture increases epigenetic dysregulation in a mouse model
|
|
158 | Eric Alejandro Rhon Calderon | Apr 24, 2024 | |||
GSE240713 |
Impact of Folate Status on the Sperm DNA Methylome of Mice with the 677C>T Variant in 5,10-Methylenetetrahydrofolate Reductase
|
|
24 |
|
Jacquetta Trasler | Apr 17, 2024 | ||
GSE240833 |
Maternal oxytocin treatment at birth increases epigenetic age in male offspring [array]
|
|
|
8 | Joshua Danoff | Apr 03, 2024 | ||
GSE240856 |
Maternal oxytocin treatment at birth increases epigenetic age in male offspring
|
|
|
14 | Joshua Danoff | Apr 03, 2024 | ||
GSE262711 |
Developmental priming of cancer susceptibility [DNA methylation array - d10earclips_2nd cohort]
|
|
22 |
|
Luca Fagnocchi | Mar 29, 2024 | ||
GSE262712 |
Developmental priming of cancer susceptibility [DNA methylation array - healthyTissues]
|
|
46 |
|
Luca Fagnocchi | Mar 29, 2024 | ||
GSE262713 |
Developmental priming of cancer susceptibility
|
|
182 | Luca Fagnocchi | Mar 29, 2024 | |||
GSE247179 |
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation [Array]
|
|
|
36 |
|
Wayne Mitchell | Mar 21, 2024 | |
GSE247199 |
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation
|
|
|
60 | Wayne Mitchell | Mar 21, 2024 | ||
GSE238173 |
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) [MouseMethylation]
|
|
12 | Claudia Theys | Mar 01, 2024 | |||
GSE239279 |
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
|
|
24 | Claudia Theys | Mar 01, 2024 | |||
GSE224349 |
TET1 catalytic activity is required for reprogrammign of imprinting control regions and the patterning of sperm-specific hypomethylated regions [Mouse Methylation285 12v1-0 BeadChip]
|
|
36 | Rexxi Diptya Prasasya | Feb 27, 2024 | |||
GSE239290 |
Optimizing the experimental and computational methods for Infinium DNA methylation BeadChip on low input and single cells
|
|
146 |
|
Wanding Zhou | Feb 27, 2024 | ||
GSE224459 |
TET1 catalytic activity is required for reprogrammign of imprinting control regions and the patterning of sperm-specific hypomethylated regions
|
|
63 |
|
Rexxi Diptya Prasasya | Feb 26, 2024 | ||
GSE252722 |
Endocrine disruptor-induced epimutagenesis in vitro: Insight into molecular mechanisms [Infinium]
|
|
30 | Jake Dean Lehle | Jan 31, 2024 | |||
GSE252723 |
Endocrine disruptor-induced epimutagenesis in vitro: Insight into molecular mechanisms
|
|
84 |
|
Jake Dean Lehle | Jan 31, 2024 |